DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Multaq - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Multaq API intelligence over Multaq and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Mycamine - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Mycamine API intelligence over Mycamine and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Myfortic - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Myfortic API intelligence over Myfortic and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Namenda - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Namenda API intelligence over Namenda and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Nebivololo Mylan - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Nebivololo Mylan API intelligence over Nebivololo Mylan and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Nesina - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Nesina API intelligence over Nesina and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Neurontin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Neurontin API intelligence over Neurontin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Nexavar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Nexavar API intelligence over Nexavar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Nexplanon - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Nexplanon API intelligence over Nexplanon and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Niaspan LP - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Niaspan LP API intelligence over Niaspan LP and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Norvasc - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Norvasc API intelligence over Norvasc and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Norvir SEC - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Norvir SEC API intelligence over Norvir SEC and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Novothyrox - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Novothyrox API intelligence over Novothyrox and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Nuvaring - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Nuvaring API intelligence over Nuvaring and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Nuvigil - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Nuvigil API intelligence over Nuvigil and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Onglyza - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Onglyza API intelligence over Onglyza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Opana ER - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Opana ER API intelligence over Opana ER and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Optruma - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Optruma API intelligence over Optruma and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Pariet - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Pariet API intelligence over Pariet and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Pentasa Enema - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Pentasa Enema API intelligence over Pentasa Enema and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Plavix - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Plavix API intelligence over Plavix and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Pletal - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Pletal API intelligence over Pletal and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Prezista - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Prezista API intelligence over Prezista and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Prilosec - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Prilosec API intelligence over Prilosec and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Pristiq - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Pristiq API intelligence over Pristiq and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Proemend - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Proemend API intelligence over Proemend and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Prograf - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Prograf API intelligence over Prograf and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Propecia - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Propecia API intelligence over Propecia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Proscar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Proscar API intelligence over Proscar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Protopic - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Protopic API intelligence over Protopic and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Pulmicort Turbuhaler - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Pulmicort Turbuhaler API intelligence over Pulmicort Turbuhaler and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Qvarspray - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Qvarspray API intelligence over Qvarspray and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Ranexa - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Ranexa API intelligence over Ranexa and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Rapamune - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Rapamune API intelligence over Rapamune and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Relpax - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Relpax API intelligence over Relpax and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Remodulin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Remodulin API intelligence over Remodulin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Restex - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Restex API intelligence over Restex and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Revlimid - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Revlimid API intelligence over Revlimid and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Reyataz - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Reyataz API intelligence over Reyataz and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Rezaltas - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Rezaltas API intelligence over Rezaltas and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Rocephin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Rocephin API intelligence over Rocephin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Sandostatine - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Sandostatine API intelligence over Sandostatine and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Sarcopenia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Sarcopenia Key assessments Patient Segmentation in Sarcopenia Sarcopenia Risk & Burden Factors driving growth in a specific Sarcopenia patient population
January 2022
60 pages
Sarcopenia - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Sarcopenia Sarcopenia Pipeline Analysis Sarcopenia Market Size and Trends Sarcopenia Market Opportunities Impact of upcoming Therapies in Sarcopenia Sarcopenia Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Sarcopenia ...
January 2022
200 pages
Selzentry - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Selzentry API intelligence over Selzentry and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Sensipar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Sensipar API intelligence over Sensipar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Seroquel - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Seroquel API intelligence over Seroquel and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Seroxat - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Seroxat API intelligence over Seroxat and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Sevikar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Sevikar API intelligence over Sevikar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Singulair Paediatric - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Singulair Paediatric API intelligence over Singulair Paediatric and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
